Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $56,582 - $77,349
-2,622 Reduced 13.58%
16,690 $451,000
Q3 2023

Oct 11, 2023

BUY
$25.8 - $39.97 $498,249 - $771,900
19,312 New
19,312 $572,000
Q2 2021

Jul 21, 2021

SELL
$109.77 - $165.68 $153,129 - $231,123
-1,395 Closed
0 $0
Q1 2021

Apr 27, 2021

BUY
$127.04 - $179.1 $177,220 - $249,844
1,395 New
1,395 $213,000
Q1 2020

May 07, 2020

SELL
$59.04 - $88.81 $289,118 - $434,902
-4,897 Closed
0 $0
Q4 2019

Jan 15, 2020

BUY
$59.49 - $82.78 $6,781 - $9,436
114 Added 2.38%
4,897 $383,000
Q3 2019

Nov 05, 2019

SELL
$62.59 - $110.3 $9,513 - $16,765
-152 Reduced 3.08%
4,783 $305,000
Q2 2019

Jul 22, 2019

BUY
$63.94 - $91.11 $315,543 - $449,627
4,935 New
4,935 $426,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.83B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.